Cipla′s Ugandan unit aims to raise $45mn

Cipla′s Ugandan unit aims to raise $45mn
Cipla′s Ugandan unit aims to raise $45mn

The Ugandan unit of Indian drugmaker Cipla priced its initial public offering on Tuesday at 256.5 Ugandan shillings per share, aiming to raise $45 million from its listing on the Kampala stock exchange next month. Cipla Quality Chemical Industries, which is majority owned by India′s third-largest drugmaker, is selling 657,179,319 shares, or an 18 per cent stake in the company. It makes a range of drugs including antiretrovirals, anti-malaria and Hepatitis B and C drugs, which it sells mostly in sub-Saharan African countries, and will become the 17th company to list on the Ugandan stock exchange. Emmanuel Katongole, CEO, Cipla Quality Chemical Industries Limited, said in a statement the IPO would enable Ugandan investors to share in the company′s success. Cipla, which was established in 2005 and has a manufacturing plant in Kampala, is set to make its market debut on 17 September. It said it expected to raise 168.6 billion Ugandan shillings ($45 million) in the IPO. The offer opened this week and is expected to close on 24 August. The drugmaker made a net profit of 44.6 billion shillings for the year ended in March this year.

Related Stories

No stories found.

Podcast

No stories found.

Defence bulletin

No stories found.

The power of the quad

No stories found.

Videos

No stories found.

Women Leaders

No stories found.